The feasibility and accuracy of sentinel lymph node biopsy in clinically node-negative patients after neoadjuvant chemotherapy for breast cancer - A systematic review and meta-analysis

Journal of Surgical Oncology

Volumn 104, Issue 1, 2011, Pages 97-103

  Tan, Veronique K M ^a   Goh, Brian K P ^a   Fook Chong, Stephanie ^a   Khin, Lay Wai ^b   Wong, Wai Keong ^a   Yong, Wei Sean ^c  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

Breast cancer; Neoadjuvant chemotherapy; Sentinel lymph node biopsy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; PACLITAXEL;

ACCURACY; ADJUVANT CHEMOTHERAPY; BREAST CANCER; COCHRANE LIBRARY; DIAGNOSTIC TEST ACCURACY STUDY; FEASIBILITY STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PUBLISHING; REVIEW; SENTINEL LYMPH NODE BIOPSY; SYSTEMATIC REVIEW;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEASIBILITY STUDIES; FEMALE; HUMANS; LYMPH NODES; META-ANALYSIS AS TOPIC; SENTINEL LYMPH NODE BIOPSY;

EID: 79958124113     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21911     Document Type: Review

References (38)

1. Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-187. (Pubitemid 19032001)
2. Fitzgibbons PL, Page DL, Weaver D, et al.: Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:966-978.
3. Benson EA, Thorogood J: The effect of surgical technique on local recurrence rates following mastectomy. Eur J Surg Oncol 1986;12:267-271. (Pubitemid 16006972)
4. Hack TF, Cohen L, Katz J, et al.: Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 1999;17:143-149. (Pubitemid 29022387)
5. Maunsell E, Brisson J, Deschenes L: Arm problems and psychological distress after surgery for breast cancer. Can J Surg 1993;36:315-320. (Pubitemid 23302269)
6. Lyman GH, Giuliano AE, Somerfield MR, et al.: American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703-7720. (Pubitemid 46291835)
7. Miltenburg DM, Miller C, Karamlou TB, et al.: Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res 1999;84:138-142. (Pubitemid 29389989)
8. Dowlatshahi K, Fan M, Anderson JM, et al.: Occult metastases in sentinel nodes of 200 patients with operable breast cancer. Ann Surg Oncol 2001;8:675-681. (Pubitemid 32847934)
9. NCCN. NCCN Clinical Pracitce Guidelines in Oncology. http:// wwwnccnorg/physician-gls/f-guidelineshtml.
10. Chen AM, Meric-Bernstam F, Hunt KK, et al.: Breast conservation after neoadjuvant chemotherapy: The MD Anderson cancer center experience. J Clin Oncol 2004;22:2303-2312. (Pubitemid 41115386)
11. Loibl S, von Minckwitz G, Raab G, et al.: Surgical procedures after neoadjuvant chemotherapy in operable breast cancer: Results of the GEPARDUO trial. Ann Surg Oncol 2006;13: 1434-1442. (Pubitemid 44749654)
12. Kuerer HM, Sahin AA, Hunt KK, et al.: Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 1999;230:72-78. (Pubitemid 30190367)
13. Kuerer HM, Newman LA, Fornage BD, et al.: Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer. Ann Surg Oncol 1998;5:673-680. (Pubitemid 28565717)
14. Vlastos G, Mirza NQ, Lenert JT, et al.: The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy. Cancer 2000;88:1417-1424. (Pubitemid 30155180)
15. Sharkey FE, Addington SL, Fowler LJ, et al.: Effects of preoperative chemotherapy on the morphology of resectable breast carcinoma. Mod Pathol 1996;9:893-900. (Pubitemid 26319719)
16. Xing Y, Foy M, Cox DD, et al.: Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 2006;93:539-546.
17. Kelly AM, Dwamena B, Cronin P, et al.: Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy - Systematic review and meta analysis. Acad Radiol 2009;16:551-563.
18. van Deurzen CH, Vriens BE, Tjan-Heijnen VC, et al.: Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: A systematic review. Eur J Cancer 2009;45:3124-3130.
19. Whiting P, Rutjes AW, Reitsma JB, et al.: The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25.
20. Higgins JP, Thompson SG, Deeks JJ, et al.: Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560. (Pubitemid 37088507)
21. Nason KS, Anderson BO, Byrd DR, et al.: Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 2000;89:2187-2194.
22. Tafra L, Verbanac KM, Lannin DR: Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. Am J Surg 2001;182:312-315. (Pubitemid 33079077)
23. Miller AR, Thomason VE, Yeh IT, et al.: Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma. Ann Surg Oncol 2002;9:243-247. (Pubitemid 34298628)
24. Balch GC, Mithani SK, Richards KR, et al.: Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer. Ann Surg Oncol 2003;10:616-621. (Pubitemid 40486892)
25. Piato JR, Barros AC, Pincerato KM, et al.: Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study. Eur J Surg Oncol 2003;29:118-120. (Pubitemid 36367342)
26. Schwartz GF, Meltzer AJ: Accuracy of axillary sentinel lymph node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast. Breast J 2003;9:374-379. (Pubitemid 37158910)
27. Tanaka Y, Maeda H, Ogawa Y, et al.: Sentinel node biopsy in breast cancer patients treated with neoadjuvant chemotherapy. Oncol Rep 2006;15:927-931.
28. Kinoshita T: Sentinel lymph node biopsy is feasible for breast cancer patients after neoadjuvant chemotherapy. Breast Cancer 2007;14:10-15.
29. Yu JC, Hsu GC, Hsieh CB, et al.: Role of sentinel lymphadenectomy combined with intraoperative ultrasound in the assessment of locally advanced breast cancer after neoadjuvant chemotherapy. Ann Surg Oncol 2007;14:174-180.
30. Papa MZ, Zippel D, Kaufman B, et al.: Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer. J Surg Oncol 2008;98:403-406.
31. Fisher B, Brown A, Mamounas E, et al.: Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997;15:2483-2493. (Pubitemid 27289876)
32. Bear HD, Anderson S, Smith RE, et al.: Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 2006;24:2019-2027. (Pubitemid 46622110)
33. Shen J, Gilcrease MZ, Babiera GV, et al.: Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 2007;109:1255-1263. (Pubitemid 46466551)
34. McMasters KM, Tuttle TM, Carlson DJ, et al.: Sentinel lymph node biopsy for breast cancer: A suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000;18:2560-2566. (Pubitemid 30432522)
35. Krag DN, Anderson SJ, Julian TB, et al.: Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymphnode dissection in patients with clinically node-negative breast cancer: Results from the NSABP-32 randomised phase III trial. Lancet Oncol 2007;8:881-888. (Pubitemid 47488052)
36. Kim T, Giuliano AE, Lyman GH: Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: A metaanalysis. Cancer 2006;106:4-16. (Pubitemid 43033320)
37. McMasters KM, Wong SL, Chao C, et al.: Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: A model for implementation of new surgical techniques. Ann Surg 2001;234:292-299, discussion 299-300.
38. Cox CE, Salud CJ, Cantor A, et al.: Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. J Am Coll Surg 2001;193:593-600. (Pubitemid 33111529)